| Literature DB >> 32418899 |
Jun-O Jin1, Gyurin Kim2, Juyoung Hwang3, Kyung Ho Han4, Minseok Kwak5, Peter C W Lee6.
Abstract
Cancer is one of the most prevalent potentially lethal diseases. With the increase in the number of investigations into the uses of nanotechnology, many nucleic acid (NA)-based nanostructures such as small interfering RNA, microRNA, aptamers, and immune adjuvant NA have been applied to treat cancer. Here, we discuss studies on the applications of NA in cancer treatment, recent research trends, and the limitations and prospects of specific NA-mediated gene therapy and immunotherapy for cancer treatment. The NA structures used for cancer therapy consist only of NA or hybrids comprising organic or inorganic substances integrated with functional NA. We also discuss delivery vehicles for therapeutic NA and anti-cancer agents, and recent trends in NA-based gene therapy and immunotherapy against cancer.Entities:
Keywords: Cancer therapy; Gene therapy; Immunotherapy; Nanoparticle; Nucleic acid
Year: 2020 PMID: 32418899 DOI: 10.1016/j.bbcan.2020.188377
Source DB: PubMed Journal: Biochim Biophys Acta Rev Cancer ISSN: 0304-419X Impact factor: 10.680